Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
Organogenesis Holdings Inc., a regenerative medicine company specializing in advanced wound care and surgical and sports medicine products, announced it will report its second quarter fiscal 2026 financial results on August 6, 2026, followed by a management conference call.